Prostate cancer decisions — 2022

The Board denied readjudication of the service connection claims for bilateral hearing loss and tinnitus due to lack of new and relevant evidence. Service connection was granted for diabetes mellitus type 2, prostate cancer, chronic lymphocytic leukemia, and erectile dysfunction (ED) as secondary to prostate cancer.

The Board denied readjudication of the service connection claims for bilateral hearing loss and tinnitus due to lack of new and relevant evidence. Service connection was granted for diabetes mellitus type 2, prostate cancer, chronic lymphocytic leukemia, and erectile dysfunction (ED) as secondary to prostate cancer.

The Board denied readjudication of the service connection claims for bilateral hearing loss and tinnitus due to lack of new and relevant evidence. Service connection was granted for diabetes mellitus type 2, prostate cancer, chronic lymphocytic leukemia, and erectile dysfunction (ED) as secondary to prostate cancer.

The Veteran's service-connected residuals of prostate cancer, erectile dysfunction, and hypertension are all found to be related to his in-service exposure to herbicide agents, specifically Agent Orange.

The Board has remanded the case due to insufficient evidence regarding the Veteran's exposure to herbicide agents and his prostate cancer. The Veteran is presumed exposed to herbicide agents, but there is not enough information about specific aircraft he flew on to establish presumptive service connection.

The appeal of the service connection claims for multiple conditions has been dismissed due to the appellant's death.

The Board has granted a rating of 60 percent for prostate cancer residuals based on voiding dysfunction, effective from the date of the reduction decision. The Veteran's previous total disability evaluation was reduced due to lack of ongoing therapeutic treatment and no local recurrence or metastasis.

The Board has remanded the claims due to a failure to consider pending claims in relation to the above-captioned claims, and for further development of these claims.

The Board has determined that new and relevant evidence has been submitted to support the reopening of claims for service connection for various conditions, including heart disorder, stroke, kidney disorder, lumbar spine disorder, prostate cancer, acquired psychiatric disorder (secondary to a lumbar spine disorder), and bilateral eye disorder. The issues have been remanded due to pre-decisional duty to assist errors.

The Veteran's prostate cancer is granted as service connected due to presumed exposure to herbicides during his Vietnam War service.

The Board has determined that new and relevant evidence has been submitted to support the reopening of claims for service connection for various conditions, including heart disorder, stroke, kidney disorder, lumbar spine disorder, prostate cancer, acquired psychiatric disorder (secondary to a lumbar spine disorder), and bilateral eye disorder. The issues have been remanded due to pre-decisional duty to assist errors.

The Board has remanded the claim of service connection for prostate cancer, including as due to herbicide exposure, due to inadequate compliance with prior directives and need for clarification on the issue.

The Veteran's prostate cancer residuals are granted a 20% disability rating effective May 1, 2018. The Veteran's PTSD is denied any increase in the current 70% disability rating.

The Board has remanded the claims for service connection due to inadequate development and compliance with previous directives.

The Board has remanded the cases for additional development due to non-compliance with prior remand directives, specifically obtaining all outstanding VA treatment records from the Philadelphia VAMC.

The Veteran's appeal for a rating in excess of 60 percent for prostate cancer is dismissed as he withdrew his claim. The Board also remanded the issue of compensation under 38 U.S.C. § 1151 for additional disability from a February 2021 VA colonoscopy, to include residuals of perforated colon.

The Veteran's prostate cancer residuals are not entitled to a higher disability rating than currently assigned. The restoration of the 20 percent ratings for diabetic peripheral neuropathy of the femoral nerve in both lower extremities is granted.

The Veteran's ischemic heart disease and prostate cancer are presumed to have been caused by his exposure to herbicide agents, including Agent Orange, during service in Vietnam. Service connection is granted for these conditions.

The Veteran's claim for an earlier effective date of service connection for prostate cancer was granted, with the effective date set at April 30, 2010.

The Board has granted service connection for prostate cancer and squamous cell carcinoma of the nasal septum under the PACT Act, which provides presumptive service connection.